NO20092336L - O-substituerte-dibenzyl urea-derivater som TRPV 1 reseptorantagonister - Google Patents

O-substituerte-dibenzyl urea-derivater som TRPV 1 reseptorantagonister

Info

Publication number: NO20092336L
Authority: NO; Norway
Prior art keywords: hydroxypropyl; pain; trpv; substituted; dihydroxypropyl
Prior art date: 2006-12-21

Application number

NO20092336A

Other languages

English (en)

Norwegian (no)

Inventor

Pier Giovanni Baraldi

Pier Andrea Borea

Pierangelo Geppetti

Francesca Fruttarolo

Maria Giovanna Pavani

Marcello Trevisani

Original Assignee

Pharmeste Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-21

Filing date

2009-06-18

Publication date

2009-06-18

2009-06-18 Application filed by Pharmeste Srl filed Critical Pharmeste Srl

2009-06-18 Publication of NO20092336L publication Critical patent/NO20092336L/no

Links

108010025083 TRPV1 receptor Proteins 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1
-1 2,3-dihydroxypropyl Chemical group 0.000 abstract 9
125000000217 alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 abstract 1
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 abstract 1
125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 abstract 1
125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 abstract 1
125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 abstract 1
208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
208000004454 Hyperalgesia Diseases 0.000 abstract 1
208000035154 Hyperesthesia Diseases 0.000 abstract 1
206010020853 Hypertonic bladder Diseases 0.000 abstract 1
208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
208000002193 Pain Diseases 0.000 abstract 1
208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
206010045171 Tumour pain Diseases 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
238000000605 extraction Methods 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
208000014617 hemorrhoid Diseases 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
230000004968 inflammatory condition Effects 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 abstract 1
208000004296 neuralgia Diseases 0.000 abstract 1
208000021722 neuropathic pain Diseases 0.000 abstract 1
208000020629 overactive bladder Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
210000002345 respiratory system Anatomy 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20092336A 2006-12-21 2009-06-18 O-substituerte-dibenzyl urea-derivater som TRPV 1 reseptorantagonister NO20092336L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06026533A EP1939173A1 (en)	2006-12-21	2006-12-21	O-substituted-dibenzyl urea- or thiourea- derivatives as trpv1 receptor antagonists
PCT/IB2007/003784 WO2008075150A1 (en)	2006-12-21	2007-12-06	O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists

Publications (1)

Publication Number	Publication Date
NO20092336L true NO20092336L (no)	2009-06-18

Family

ID=38139789

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20092336A NO20092336L (no)	2006-12-21	2009-06-18	O-substituerte-dibenzyl urea-derivater som TRPV 1 reseptorantagonister

Country Status (25)

Country	Link
US (1)	US7750049B2 (sr)
EP (2)	EP1939173A1 (sr)
JP (1)	JP5302214B2 (sr)
KR (1)	KR101460177B1 (sr)
CN (1)	CN101563317B (sr)
AT (1)	ATE479652T1 (sr)
BR (1)	BRPI0720421A2 (sr)
CA (1)	CA2673219C (sr)
CY (1)	CY1110833T1 (sr)
DE (1)	DE602007008942D1 (sr)
DK (1)	DK2094653T3 (sr)
EA (1)	EA015152B1 (sr)
ES (1)	ES2347492T3 (sr)
HR (1)	HRP20100588T1 (sr)
IL (1)	IL199422A (sr)
MX (1)	MX2009006582A (sr)
NO (1)	NO20092336L (sr)
NZ (1)	NZ577796A (sr)
PL (1)	PL2094653T3 (sr)
PT (1)	PT2094653E (sr)
RS (1)	RS51555B (sr)
SI (1)	SI2094653T1 (sr)
UA (1)	UA95986C2 (sr)
WO (1)	WO2008075150A1 (sr)
ZA (1)	ZA200904278B (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8765815B2 (en)	2007-09-20	2014-07-01	Ramot At Tel-Aviv University Ltd.	N-phenyl anthranilic acid derivatives and uses thereof
WO2018099570A1 (en)	2016-12-02	2018-06-07	Symrise Ag	Cosmetic blends
RU2755206C1 (ru)	2020-05-20	2021-09-14	Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН)	Средство пролонгированного анальгетического действия и лекарственный препарат на его основе

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8715357D0 (en) *	1987-06-30	1987-08-05	Sandoz Inst For Medical Resear	Organic compounds
GB9519270D0 (en) *	1995-09-21	1995-11-22	Sandoz Pharma Uk	Organic compounds
KR100564902B1 (ko) *	2000-08-21	2006-03-30	주식회사 태평양	신규 티오우레아 유도체 및 이를 함유하는 약제학적 조성물
JP2003192660A (ja) *	2001-12-26	2003-07-09	Bayer Ag	尿素誘導体
US6858615B2 (en) *	2002-02-19	2005-02-22	Parion Sciences, Inc.	Phenyl guanidine sodium channel blockers
ITMI20041231A1 (it) *	2004-06-18	2004-09-18	Pharmeste Srl	Antagonisti del recettore dei vanilloidi trpv1

2006
- 2006-12-21 EP EP06026533A patent/EP1939173A1/en not_active Withdrawn
2007
- 2007-06-12 UA UAA200904805A patent/UA95986C2/uk unknown
- 2007-12-06 ZA ZA200904278A patent/ZA200904278B/xx unknown
- 2007-12-06 JP JP2009542247A patent/JP5302214B2/ja active Active
- 2007-12-06 DE DE602007008942T patent/DE602007008942D1/de active Active
- 2007-12-06 NZ NZ577796A patent/NZ577796A/en not_active IP Right Cessation
- 2007-12-06 PL PL07848984T patent/PL2094653T3/pl unknown
- 2007-12-06 CA CA2673219A patent/CA2673219C/en active Active
- 2007-12-06 PT PT07848984T patent/PT2094653E/pt unknown
- 2007-12-06 RS RSP-2010/0441A patent/RS51555B/sr unknown
- 2007-12-06 ES ES07848984T patent/ES2347492T3/es active Active
- 2007-12-06 EP EP07848984A patent/EP2094653B1/en active Active
- 2007-12-06 KR KR1020097012641A patent/KR101460177B1/ko not_active Expired - Fee Related
- 2007-12-06 US US12/519,753 patent/US7750049B2/en active Active
- 2007-12-06 WO PCT/IB2007/003784 patent/WO2008075150A1/en not_active Ceased
- 2007-12-06 CN CN2007800469258A patent/CN101563317B/zh active Active
- 2007-12-06 SI SI200730412T patent/SI2094653T1/sl unknown
- 2007-12-06 AT AT07848984T patent/ATE479652T1/de active
- 2007-12-06 BR BRPI0720421-3A patent/BRPI0720421A2/pt not_active IP Right Cessation
- 2007-12-06 MX MX2009006582A patent/MX2009006582A/es active IP Right Grant
- 2007-12-06 DK DK07848984.6T patent/DK2094653T3/da active
- 2007-12-06 EA EA200900625A patent/EA015152B1/ru not_active IP Right Cessation
- 2007-12-06 HR HR20100588T patent/HRP20100588T1/hr unknown
2009
- 2009-06-18 IL IL199422A patent/IL199422A/en active IP Right Grant
- 2009-06-18 NO NO20092336A patent/NO20092336L/no not_active Application Discontinuation
2010
- 2010-10-18 CY CY20101100925T patent/CY1110833T1/el unknown

Also Published As

Publication number	Publication date
DK2094653T3 (da)	2010-10-25
PT2094653E (pt)	2010-09-23
IL199422A (en)	2015-01-29
JP5302214B2 (ja)	2013-10-02
DE602007008942D1 (de)	2010-10-14
RS51555B (sr)	2011-06-30
KR101460177B1 (ko)	2014-11-10
ES2347492T3 (es)	2010-10-29
CY1110833T1 (el)	2015-06-10
EA015152B1 (ru)	2011-06-30
SI2094653T1 (sl)	2011-01-31
US7750049B2 (en)	2010-07-06
PL2094653T3 (pl)	2011-02-28
CN101563317B (zh)	2012-12-12
ZA200904278B (en)	2010-08-25
HRP20100588T1 (hr)	2010-12-31
CA2673219A1 (en)	2008-06-26
KR20090090347A (ko)	2009-08-25
ATE479652T1 (de)	2010-09-15
EA200900625A1 (ru)	2009-12-30
CA2673219C (en)	2015-04-14
US20100105740A1 (en)	2010-04-29
EP1939173A1 (en)	2008-07-02
EP2094653B1 (en)	2010-09-01
WO2008075150A1 (en)	2008-06-26
BRPI0720421A2 (pt)	2013-12-31
CN101563317A (zh)	2009-10-21
JP2010513455A (ja)	2010-04-30
MX2009006582A (es)	2009-07-02
NZ577796A (en)	2011-10-28
UA95986C2 (uk)	2011-09-26
EP2094653A1 (en)	2009-09-02

Legal Events

Date	Code	Title	Description
2018-07-09	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20092286L (no)	2009-08-13	Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20063468L (no)	2006-11-15	Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20063599L (no)	2006-10-27	Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20073791L (no)	2007-08-30	Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20072371L (no)	2007-07-12	Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
NO20085121L (no)	2009-01-27	Benzimidazolderivater, deres fremstillingsmate, deres anvendelse som FXR-agonister og farmasoytiske blandinger inneholdende samme
WO2009155121A3 (en)	2010-02-18	Inhibitors of pi3 kinase
ATE307810T1 (de)	2005-11-15	Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
NO20083690L (no)	2008-09-18	Hydantoin baserte kinase-inhibitorer
NO20082496L (no)	2008-07-24	Pyrazinderivater
NO20090979L (no)	2009-05-06	(3-amino-1,2,3,4-tetrahydro-9H-karbazol-9-yl)-eddiksyrederivater
WO2012028332A8 (en)	2013-03-07	Pharmaceutically active compounds as axl inhibitors
WO2008075172A3 (en)	2008-10-02	Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
WO2005075425A3 (en)	2006-12-14	Substituted bisarylurea derivatives as kinase inhibitors
WO2010059239A3 (en)	2010-08-05	Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
NO20082346L (no)	2008-08-04	Hydrazonderivater og anvendelser derav
GEP20125459B (en)	2012-03-26	Compounds for inhibiting mitotic progression
NO20083708L (no)	2008-09-23	4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
NO20056192L (no)	2005-12-27	Kapaseinhibitorer og anvendelse derav
NO20084363L (no)	2008-11-17	2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister
NO20080161L (no)	2008-01-28	Aminopyrimidiner som kinasemodulatorer
NO20080174L (no)	2008-02-19	Alkylquinolin- og alkylquinazolinkinasemodulatorer
EA200970065A1 (ru)	2009-06-30	Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
EA201071269A1 (ru)	2011-06-30	3,4-замещенные пиперидиновые производные в качестве ингибиторов ренина